These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Bielekova B, Goodwin B, Richert N, Cortese I, Kondo T, Afshar G, Gran B, Eaton J, Antel J, Frank JA, McFarland HF, Martin R. Nat Med; 2000 Oct; 6(10):1167-75. PubMed ID: 11017150 [Abstract] [Full Text] [Related]
3. Molecule of the month. Dirucotide. Drug News Perspect; 2008 Dec; 21(10):572. PubMed ID: 19221637 [No Abstract] [Full Text] [Related]
4. Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosis. Katsara M, Deraos G, Tselios T, Matsoukas MT, Friligou I, Matsoukas J, Apostolopoulos V. J Med Chem; 2009 Jan 08; 52(1):214-8. PubMed ID: 19072222 [Abstract] [Full Text] [Related]
5. Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice. Katsara M, Deraos G, Tselios T, Matsoukas J, Apostolopoulos V. J Med Chem; 2008 Jul 10; 51(13):3971-8. PubMed ID: 18563891 [Abstract] [Full Text] [Related]
6. BHT-3009, a myelin basic protein-encoding plasmid for the treatment of multiple sclerosis. Correale J, Fiol M. Curr Opin Mol Ther; 2009 Aug 10; 11(4):463-70. PubMed ID: 19649992 [Abstract] [Full Text] [Related]
7. A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg91, Ala96] MBP87-99. Mantzourani ED, Tselios TV, Grdadolnik SG, Brancale A, Platts JA, Matsoukas JM, Mavromoustakos TM. J Mol Graph Model; 2006 Sep 10; 25(1):17-29. PubMed ID: 16310386 [Abstract] [Full Text] [Related]
8. Synthesis and study of the electrophoretic behavior of mannan conjugates with cyclic peptide analogue of myelin basic protein using lysine-glycine linker. Tselios TV, Lamari FN, Karathanasopoulou I, Katsara M, Apostolopoulos V, Pietersz GA, Matsoukas JM, Karamanos NK. Anal Biochem; 2005 Dec 01; 347(1):121-8. PubMed ID: 16246290 [Abstract] [Full Text] [Related]
11. Specific immunotherapy: one size does not fit all. Genain CP, Zamvil SS. Nat Med; 2000 Oct 01; 6(10):1098-100. PubMed ID: 11017135 [No Abstract] [Full Text] [Related]
13. Citrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP(87-99)) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: implications in triggering disease. Deraos G, Chatzantoni K, Matsoukas MT, Tselios T, Deraos S, Katsara M, Papathanasopoulos P, Vynios D, Apostolopoulos V, Mouzaki A, Matsoukas J. J Med Chem; 2008 Dec 25; 51(24):7834-42. PubMed ID: 19053745 [Abstract] [Full Text] [Related]
19. Phosphorylation of U24 from Human Herpes Virus type 6 (HHV-6) and its potential role in mimicking myelin basic protein (MBP) in multiple sclerosis. Tait AR, Straus SK. FEBS Lett; 2008 Aug 06; 582(18):2685-8. PubMed ID: 18616943 [Abstract] [Full Text] [Related]